LINC01854: A Long Intergenic Non-Protein-Coding RNA (G151121)

Target Name: LINC01854

NCBI ID: G151121

LINC01854

Other Name(s): long intergenic non-protein coding RNA 1854 | Long intergenic non-protein coding RNA 1854, transcript variant 3 | Long intergenic non-protein coding RNA 1854, transcript variant 1 | Uncharacterized LOC151121 | Long intergenic non-protein coding RNA 1854, transcript variant 2 | LOC151121

LINC01854: A Long Intergenic Non-Protein-Coding RNA

Non-Protein-Coding RNAs (NP-CsRNAs) have emerged as a promising new class of molecules in recent years. These RNAs are not composed of amino acids and are not involved in protein synthesis, but they play important roles in various cellular processes. One of the key features of NP-CsRNAs is their ability to be expressed in high levels in different cell types and to remain stable over time. These properties make them useful models for understanding gene regulation and cellular signaling.

One of the defining features of NP-CsRNAs is their ability to be expressed in a highly stable manner, even in the absence of any external cues. One of the best-studied examples of this is LINC01854, a NP-CsRNA that has been shown to play important roles in various cellular processes, including cell signaling, DNA replication, and repair.

LINC01854 is a long intergenic non-protein-coding RNA (lncRNA), which means it is longer than most proteins and has a non-protein-coding structure. LINC01854 is approximately 2.6 kb in length and has a calculated exon number of 218.

The functions of LINC01854 are not well understood, but its expression is highly regulated in various cellular contexts. For example, LINC01854 is highly expressed in the brain and has been shown to play important roles in the development and progression of various neurological diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its expression in the brain, LINC01854 has also been shown to play important roles in the regulation of cell signaling pathways. For example, LINC01854 has been shown to play a role in the regulation of the PI3K/Akt signaling pathway, a pathway that is involved in various cellular processes, including cell signaling, cell survival, and cell reproduction.

The regulation of the PI3K/Akt signaling pathway by LINC01854 is associated with the development of various diseases, including cancer. For example, LINC01854 has been shown to play a role in the regulation of the growth and survival of cancer cells. In addition, LINC01854 has also been shown to play a role in the regulation of the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

The functions of LINC01854 are not well understood, but its expression is highly regulated in various cellular contexts. Its regulation by various signaling pathways suggests that it may be a useful drug target or biomarker for a variety of diseases. Further research is needed to fully understand the functions of LINC01854 and its potential utility as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1854

The "LINC01854 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01854 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets